Picture of Alzinova AB logo

ALZ Alzinova AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Alzinova Initiates Development Of A Stable Cell Line To Prepare The Monoclonal Antibody Alz-201 For Alzheimer's Clinical Trials

May 24 (Reuters) - Alzinova AB  ALZ.ST :
    * ALZINOVA INITIATES DEVELOPMENT OF A STABLE CELL LINE TO
PREPARE
THE MONOCLONAL ANTIBODY ALZ-201 FOR ALZHEIMER'S CLINICAL TRIALS

Source text for Eikon:  ID:nPn6Yx76ga 
Further company coverage:  ALZ.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alzinova AB

See all news